DV
Dividend Vision

SGRY Stock — Surgery Partners, Inc.

Surgery Partners, Inc. (SGRY)

Updated October 16, 2026.

SGRY is a Stock. Total return is -19.3% over the past 11 years, 394.5 points behind SPY at 375.2%.

Surgery Partners owns and operates a network of surgical facilities and ancillary services across the United States, including ambulatory surgery centers and surgical hospitals that provide non-emergency procedures in specialties such as orthopedics, ophthalmology, and gastroenterology, along with emergency departments, physician practices, and diagnostic testing services. The company does not currently have an established distribution schedule. This business appeals to investors seeking exposure to healthcare services and surgical facility operations.

SGRY performance versus SPY

Price and return data through 2026-10-16.

Total return is -19.3% over the past 11 years, 394.5 points behind SPY at 375.2%. Over the past year its total return — price change plus distributions reinvested — is -30.9%. Its deepest 1-year drawdown was 49.9%.

WindowTotal returnCAGR
1M4.9%—
3M-12.2%—
6M8.8%—
YTD-5.4%—
1Y-30.9%—
2Y CAGR—-33.20%
3Y CAGR—-15.10%
5Y CAGR—-18.60%
10Y CAGR—-3.10%
Since inception (11 years)-19.3%-1.90%

SGRY key facts

Asset type
Stock
Asset class
Equity
Inception date
10/01/2015
Distribution frequency
None
Last close
$14.61 (as of 2026-10-16)
Market cap
$1,912,715,779
Average volume
966776.0
Beta
1.907
Payout ratio
0.0%
Forward P/E
18.9036
EPS
$-0.69

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

SGRY risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 49.9%.

Who may consider SGRY — and who may not

It is a weaker fit for investors who need monthly cash flow (SGRY does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on SGRY

Tagged: Healthcare.

Frequently asked questions

Does SGRY pay monthly?

No. SGRY does not currently distribute.

When does SGRY pay a dividend?

SGRY does not currently distribute.

How has SGRY performed?

Total return is -19.3% over the past 11 years, 394.5 points behind SPY at 375.2%. Over the past year its total return — price change plus distributions reinvested — is -30.9%. Its deepest 1-year drawdown was 49.9%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.